Arno Therapeutics, Inc. filed its 10-K on Mar 31, 2015 for the period ending Dec 31, 2014. In this report its auditor, Crowe Horwath LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0003 USD | +417.24% | -.--% | +200.00% |
2017 | Arno Therapeutics, Inc. Terminates Licensing Agreement with Ohio State University | CI |
2017 | Arno Therapeutics Seeks Acquisitions | CI |
1st Jan change | Capi. | |
---|---|---|
+200.00% | 14.8K | |
+8.02% | 101B | |
+8.29% | 42.63B | |
+82.32% | 29.77B | |
-11.82% | 16.14B | |
+1.39% | 14.31B | |
-12.13% | 11.55B | |
+176.65% | 10.53B | |
+6.74% | 9.2B | |
-55.52% | 8.98B |
- Stock Market
- Equities
- ARNI Stock
- News Arno Therapeutics, Inc.
- Arno Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt